Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	44.29	46.86	47.01	46.98	47.64	48.14
Cash & Short-Term Investments	44.29	46.86	47.01	46.98	47.64	48.14
Cash Growth	-4.19%	-0.33%	0.06%	-1.38%	-1.04%	783.99%
Accounts Receivable	-	-	-	-	0.03	0.03
Receivables	-	-	-	-	0.03	0.03
Other Current Assets	0.44	0.29	0.33	0.41	0.09	0.06
Total Current Assets	44.74	47.15	47.34	47.39	47.75	48.23
Long-Term Deferred Tax Assets	0.04	0.02	0.36	0.2	-	-
Total Assets	44.78	47.17	47.7	47.59	47.75	48.23
Accounts Payable	0.33	0.33	0.33	0.33	0.33	0.3
Accrued Expenses	0.06	0.07	0.09	0.09	0.06	0.09
Other Current Liabilities	0.41	1.28	1.29	1.28	0.01	0.02
Total Current Liabilities	0.8	1.68	1.71	1.7	0.4	0.41
Total Liabilities	0.8	1.68	1.71	1.7	0.4	0.41
Common Stock	0.74	0.74	0.74	0.74	0.74	0.74
Additional Paid-In Capital	71.1	72.16	73.43	74.71	75.98	78.01
Retained Earnings	-71.41	-69.89	-70.67	-72.04	-71.86	-71.39
Total Common Equity	0.43	3.01	3.51	3.41	4.87	7.36
Shareholders' Equity	43.98	45.49	45.99	45.89	47.35	47.82
Total Liabilities & Equity	44.78	47.17	47.7	47.59	47.75	48.23
Net Cash (Debt)	44.29	46.86	47.01	46.98	47.64	48.14
Net Cash Growth	-4.19%	-0.33%	0.06%	-1.38%	-1.04%	783.99%
Net Cash Per Share	0.60	0.63	0.63	0.63	0.64	0.94
Filing Date Shares Outstanding	74.21	74.21	74.21	74.21	74.21	74.21
Total Common Shares Outstanding	74.21	74.21	74.21	74.21	74.21	74.21
Working Capital	43.94	45.47	45.63	45.69	47.35	47.82
Book Value Per Share	0.01	0.04	0.05	0.05	0.07	0.10
Tangible Book Value	0.43	3.01	3.51	3.41	4.87	7.36
Tangible Book Value Per Share	0.01	0.04	0.05	0.05	0.07	0.10

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.